Reducing gut microbiome-driven adipose tissue inflammation alleviates metabolic syndrome

被引:12
|
作者
Newman, N. K. [1 ]
Zhang, Y. [2 ,3 ]
Padiadpu, J. [1 ]
Miranda, C. L. [4 ]
Magana, A. A. [5 ]
Wong, C. P. [2 ]
Hioki, K. A. [1 ,6 ]
Pederson, J. W. [7 ]
Li, Z. [7 ]
Gurung, M. [7 ,8 ]
Bruce, A. M. [1 ]
Brown, K. [1 ,9 ]
Bobe, G. [10 ]
Sharpton, T. J. [11 ]
Shulzhenko, N. [7 ]
Maier, C. S. [5 ]
Stevens, J. F. [4 ]
Gombart, A. F. [12 ]
Morgun, A. [1 ]
机构
[1] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA
[2] Oregon State Univ, Linus Pauling Inst, Sch Biol & Populat Hlth Sci, Nutr Program, Corvallis, OR USA
[3] Oregon Hlth & Sci Univ, Portland, OR USA
[4] Oregon State Univ, Linus Pauling Inst, Dept Pharmaceut Sci, Corvallis, OR USA
[5] Oregon State Univ, Linus Pauling Inst, Dept Chem, Corvallis, OR USA
[6] UMass, Amherst, MA USA
[7] Oregon State Univ, Carlson Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA
[8] USDA, Children Nutr Ctr, Little Rock, AR USA
[9] Oregon State Univ, Chem Biol & Environm Engn, Corvallis, OR USA
[10] Oregon State Univ, Linus Pauling Inst, Dept Anim Sci, Corvallis, OR 97331 USA
[11] Oregon State Univ, Dept Microbiol, Dept Stat, Corvallis, OR USA
[12] Linus Pauling Inst, Dept Biochem & Biophys, Corvallis, OR 97331 USA
关键词
HUMULUS-LUPULUS L; LIPID-METABOLISM; XANTHOHUMOL; GLUCOSE; MACROPHAGES; MECHANISMS; OBESITY; HEALTH; HOST; HOP;
D O I
10.1186/s40168-023-01637-4
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
BackgroundThe gut microbiota contributes to macrophage-mediated inflammation in adipose tissue with consumption of an obesogenic diet, thus driving the development of metabolic syndrome. There is a need to identify and develop interventions that abrogate this condition. The hops-derived prenylated flavonoid xanthohumol (XN) and its semi-synthetic derivative tetrahydroxanthohumol (TXN) attenuate high-fat diet-induced obesity, hepatosteatosis, and metabolic syndrome in C57Bl/6J mice. This coincides with a decrease in pro-inflammatory gene expression in the gut and adipose tissue, together with alterations in the gut microbiota and bile acid composition.ResultsIn this study, we integrated and interrogated multi-omics data from different organs with fecal 16S rRNA sequences and systemic metabolic phenotypic data using a Transkingdom Network Analysis. By incorporating cell type information from single-cell RNA-seq data, we discovered TXN attenuates macrophage inflammatory processes in adipose tissue. TXN treatment also reduced levels of inflammation-inducing microbes, such as Oscillibacter valericigenes, that lead to adverse metabolic phenotypes. Furthermore, in vitro validation in macrophage cell lines and in vivo mouse supplementation showed addition of O. valericigenes supernatant induced the expression of metabolic macrophage signature genes that are downregulated by TXN in vivo.ConclusionsOur findings establish an important mechanism by which TXN mitigates adverse phenotypic outcomes of diet-induced obesity and metabolic syndrome. TXN primarily reduces the abundance of pro-inflammatory gut microbes that can otherwise promote macrophage-associated inflammation in white adipose tissue.7MrSGPEkxmDTc41cVX6rPoVideo AbstractConclusionsOur findings establish an important mechanism by which TXN mitigates adverse phenotypic outcomes of diet-induced obesity and metabolic syndrome. TXN primarily reduces the abundance of pro-inflammatory gut microbes that can otherwise promote macrophage-associated inflammation in white adipose tissue.7MrSGPEkxmDTc41cVX6rPoVideo Abstract
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Gut-adipose tissue crosstalk: A bridge to novel therapeutic targets in metabolic syndrome?
    Rosendo-Silva, Daniela
    Matafome, Paulo
    OBESITY REVIEWS, 2021, 22 (02)
  • [42] Visceral adipose tissue and metabolic syndrome
    Blüher, M
    Paschke, R
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2003, 128 (44) : 2319 - 2323
  • [43] Mechanisms of Chronic State of Inflammation as Mediators That Link Obese Adipose Tissue and Metabolic Syndrome
    Fuentes, Eduardo
    Fuentes, Francisco
    Vilahur, Gemma
    Badimon, Lina
    Palomo, Ivan
    MEDIATORS OF INFLAMMATION, 2013, 2013
  • [44] Relationship between energy dense diets and white adipose tissue inflammation in metabolic syndrome
    Alemany, Maria
    NUTRITION RESEARCH, 2013, 33 (01) : 1 - 11
  • [45] Colchicine effects on the gut microbiome in adults with metabolic syndrome
    Kisimba, Celine M.
    Donahue, Jack L.
    Chivukula, Krishna Karthik
    Subramanian, Poorani
    Mistry, Shreni D.
    Wolska, Anna
    Remaley, Alan T.
    Yanovski, Jack A.
    Demidowich, Andrew P.
    BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH, 2023, 42 (04) : 236 - 242
  • [46] New therapy for metabolic syndrome: Gut microbiome supplementation
    Qureshi, Waseem
    Dar, Maqsood Ahmad
    Rather, Mohd Younis
    WORLD JOURNAL OF DIABETES, 2024, 15 (09)
  • [47] Enteral nutrition in the management of acute pancreatitis: Modulates gut microbiome and alleviates inflammation
    Yang, Fang-Yuan
    Cai, Yi-Jing
    Niu, Xiao-Ying
    Wang, Shun-Fu
    Wang, Yu-Qi
    Esmie, Sabola Eluby
    Chen, Rui-Cong
    Dai, Sheng-Jie
    Kong, Hong-Ru
    Sun, Hong-Wei
    Shi, Ke- Qing
    FOOD BIOSCIENCE, 2024, 59
  • [48] The Role of the Gut Microbiome in Energy Balance With a Focus on the Gut-Adipose Tissue Axis
    Xiao, Han
    Kang, Sona
    FRONTIERS IN GENETICS, 2020, 11
  • [49] Polycystic ovary syndrome, adipose tissue and metabolic syndrome
    Alessandro P. Delitala
    Giampiero Capobianco
    Giuseppe Delitala
    Pier Luigi Cherchi
    Salvatore Dessole
    Archives of Gynecology and Obstetrics, 2017, 296 : 405 - 419
  • [50] Polycystic ovary syndrome, adipose tissue and metabolic syndrome
    Delitala, Alessandro P.
    Capobianco, Giampiero
    Delitala, Giuseppe
    Cherchi, Pier Luigi
    Dessole, Salvatore
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 296 (03) : 405 - 419